TheraLight received clearance from the U.S. Food and Drug Administrationto market its UV120-2 UVA/UUVB Phototherapy System for the treatment ofpsoriasis, vitiligo, atopic dermatitis and seborrheic dermatitis.
Clinician and Patient Perspective: Tapinarof Cream for Plaque Psoriasis
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Colorimetric Scale Offers Practical Classification in Clinical Assessment of Skin of Color
ReV Up Your Vitiligo Treatment Strategies
Addressing Disparities in Skin-Aging Prevention Among Women of Color
Biologic Therapy Linked to Increased Density of Demodex Mites and Prevalence of Demodicosis in Patients With Psoriasis vs Controls